Australian Food Stock News

ASX:4DX
ASX:4DXHealthcare Services

A Look At 4DMedical’s Valuation After Wider Half Year Losses And Stable Revenue

Earnings shock puts 4DMedical’s losses in focus 4DMedical (ASX:4DX) reported half year earnings to 31 December 2025 that kept sales near A$2.85 million, while net loss widened to A$154.14 million and basic loss per share reached A$0.311. With revenue relatively unchanged from A$2.9 million a year earlier, the size of the current loss compared with A$11.28 million previously is likely to have investors focusing closely on cash use and expense trends. See our latest analysis for...
ASX:AT4
ASX:AT4Metals and Mining

American Tungsten And Antimony’s Valuation After Upcoming Tungsten Project Update Call

Upcoming call puts tungsten projects in focus American Tungsten and Antimony (ASX:AT4) has flagged a shareholder and analyst call on 25 February 2026 to outline its tungsten strategy and recent progress at projects in Utah and Nevada. The discussion will cover updates at the Dutch Mountain Tungsten Project and Processing Facility in Utah, as well as the Tennessee Mountain and Nightingale Tungsten Projects in Nevada, giving investors more detail on how these assets fit into the company’s...
ASX:CUV
ASX:CUVBiotechs

Should Clinuvel’s Softer Half-Year Earnings Shift How Investors View Its Rare Disease Strategy (ASX:CUV)?

In February 2026, Clinuvel Pharmaceuticals Limited reported half-year results to December 31, 2025, with revenue of A$40.56 million and net income of A$10.44 million, both lower than the same period a year earlier. The year-on-year drop in basic earnings per share from A$0.281 to A$0.2082 highlights pressure on profitability despite the company’s rare disease focus. We’ll now examine how this softer half-year revenue and earnings performance affects Clinuvel’s existing investment narrative...
ASX:PME
ASX:PMEHealthcare Services

How Investors Are Reacting To Pro Medicus (ASX:PME) Insider Buying And Upcoming Dividend Amid Selling Pressure

Pro Medicus recently presented at the Morgan Stanley Technology, Media & Telecom Conference in San Francisco, while co-founders Sam Hupert and Anthony Hall purchased A$3.4 million of shares on market and shareholders prepare to receive an interim dividend on March 20. Together, the insider buying and imminent cash payout highlight management’s confidence in the business and may be refocusing investors on Pro Medicus’s fundamentals despite recent technical selling pressure. With insider...
ASX:QAN
ASX:QANAirlines

Does Qantas (ASX:QAN) Using Buybacks and Dividends Recast Its Core Capital Allocation Story?

On February 26, 2026, Qantas Airways Limited announced a share repurchase program of up to A$150 million through December 31, 2026, alongside a fully franked interim dividend of A$0.198 per share following its half-year 2025 results. Taken together, the buyback and dividend signal management’s focus on returning cash to shareholders while the business remains profitable and cash-generative. Next, we’ll examine how Qantas’s new A$150 million buyback could reshape the company’s existing...
ASX:NXT
ASX:NXTIT

Assessing NEXTDC (ASX:NXT) Valuation After Half Year 2025 Results And Narrower Net Loss

What triggered the latest focus on NEXTDC? NEXTDC (ASX:NXT) has come into focus after reporting half year results to 31 December 2025, with a net loss of A$39.35 million compared with A$42.67 million in the prior comparable period. See our latest analysis for NEXTDC. The half year result landed alongside a 1-day share price return of 1.86% and a 30-day share price return of 6.54%, while the 1-year total shareholder return is 2.78% and the 3-year total shareholder return sits at 36.73%. This...
ASX:WTC
ASX:WTCSoftware

WiseTech Global (ASX:WTC) Is Up 10.9% After Reaffirming FY26 Revenue Guidance And Dividend Payout - Has The Bull Case Changed?

WiseTech Global Limited recently reported past half-year results to December 31, 2025, with sales rising to US$672,000,000 while net income eased to US$68,100,000, and reaffirmed its fiscal 2026 revenue guidance range of US$1.39 billion to US$1.44 billion. The company also declared an estimated fully franked ordinary dividend of US$0.068 per share for the period, signalling confidence in its cash generation despite lower earnings per share. We’ll now examine how WiseTech’s reaffirmed fiscal...
ASX:TLX
ASX:TLXBiotechs

Assessing Telix Pharmaceuticals (ASX:TLX) Valuation After New AI Collaboration In Prostate Cancer Imaging

Telix Pharmaceuticals (ASX:TLX) has drawn fresh attention after announcing a collaboration with University Hospital Essen to apply artificial intelligence to the large PROMISE-PET registry for PSMA-PET imaging in prostate cancer. See our latest analysis for Telix Pharmaceuticals. The new AI collaboration comes after a period of mixed performance, with Telix’s 1-day share price return of 6.54% and 7-day return of 7.50% contrasting with a 90-day share price decline of 27.41% and a 1-year total...
ASX:JIN
ASX:JINHospitality

Assessing Jumbo Interactive (ASX:JIN) Valuation After Mixed Half Year Earnings And Dividend Cut

Jumbo Interactive (ASX:JIN) has drawn fresh attention after releasing half year results to 31 December 2025, alongside a revised fully franked interim dividend of A$0.12 per share with an ex dividend date set for 3 March. See our latest analysis for Jumbo Interactive. The earnings announcement and trimmed interim dividend came after a weak stretch for Jumbo Interactive. The 90 day share price return of 19.55% and 1 year total shareholder return of 14.11% are both in decline, despite a 1 day...
ASX:EVN
ASX:EVNMetals and Mining

Why Evolution Mining (ASX:EVN) Is Down 10.8% After Macro Jitters Hit Gold Miners

In recent days, Evolution Mining has faced heavy selling alongside other ASX-listed gold miners, as investors reacted to rising oil prices, shifting interest rate expectations, and geopolitical disruptions affecting the global gold trade, despite the company having previously reported record half-year earnings and approved new capital investments at Northparkes and Ernest Henry. At the same time, director Andrea Hall’s modest on-market share sale and prior technical indicators of strong...
ASX:WDS
ASX:WDSOil and Gas

Assessing Woodside Energy Group’s Valuation After Record FY25 Output And Higher Dividend Fuel Market Optimism

Woodside Energy Group (ASX:WDS) is back in focus after record FY25 production, an increased dividend of US$0.59 per share, and a sharp share price move linked to oil supply fears in West Asia. See our latest analysis for Woodside Energy Group. Those production records and the higher dividend have arrived alongside strong recent momentum, with a 19.0% 1 month share price return, a 29.97% year to date share price return and a 44.95% 1 year total shareholder return, suggesting sentiment has...
ASX:ZIP
ASX:ZIPConsumer Finance

A Look At Zip Co (ASX:ZIP) Valuation After Results Update And US Expansion Plans

What sparked the latest move in Zip Co shares? Zip Co (ASX:ZIP) has been back in focus after first half fiscal 2026 results, where strong income, transaction volume, and profitability met flatter second half guidance and tighter margins, prompting a rethink of the share price move. See our latest analysis for Zip Co. That 3.65% 1 day share price return to A$1.845 comes after a tougher period, with the 30 day share price return of 26.79% and year to date share price return of 44.93% both...
ASX:COH
ASX:COHMedical Equipment

Cochlear’s Nucleus Nexa Launch Prompts Fresh Look At Valuation And Future Growth Potential

What Cochlear’s Nucleus Nexa launch could mean for shareholders Cochlear (ASX:COH) has launched its Nucleus Nexa System, a smart cochlear implant with upgradeable firmware and built in memory, now available in India from March 1, 2026. This product launch adds another option to Cochlear’s implantable hearing solutions portfolio, giving investors a fresh event to consider alongside the company’s current share price and recent share performance. See our latest analysis for Cochlear. Despite...
ASX:MSB
ASX:MSBBiotechs

The Bull Case For Mesoblast (ASX:MSB) Could Change Following Surging Ryoncil Revenue And 2026 Guidance - Learn Why

In late February 2026, Mesoblast reported half-year results showing revenue of US$51.34 million, a very large increase from US$3.16 million a year earlier, alongside a narrower net loss of US$40.16 million and reduced loss per share. Soon after, the company issued fiscal 2026 guidance projecting full-year Ryoncil net revenue between US$110 million and US$120 million, giving investors a clearer view of the therapy’s commercial trajectory. With Mesoblast now guiding Ryoncil net revenue of...
ASX:TWE
ASX:TWEBeverage

Is Treasury Wine Estates' (ASX:TWE) CFO Exit the Key to a Leaner, Higher-End Portfolio Strategy?

Treasury Wine Estates has announced that Chief Financial and Strategy Officer Stuart Boxer will retire in September 2026, with an internal and external search underway and a multi‑year transformation program targeting A$100 million in annual cost savings and potential divestment of lower-priced brands. The planned, long-dated transition aims to preserve financial and operational continuity while the company reshapes its portfolio and expands production initiatives in China following the...
ASX:SUL
ASX:SULSpecialty Retail

What Super Retail Group (ASX:SUL)'s Higher Sales, Lower Earnings and Steady Dividend Mean For Shareholders

Super Retail Group Limited recently reported half-year results for the period ended 27 December 2025, with sales of A$2,194.7 million and net income of A$104.1 million, and declared a fully franked ordinary dividend of A$0.32 per share payable on 2 April 2026. The company’s higher sales but lower earnings, alongside the affirmed dividend and the appointment of Inga Kirkman as an additional Company Secretary on 26 February 2026, provide fresh insight into how it is balancing growth,...
ASX:AFI
ASX:AFICapital Markets

Assessing Australian Foundation Investment’s Valuation As Buy-Backs And Special Dividends Lift Capital Returns

Buy-back activity and special dividends put capital returns in focus Australian Foundation Investment (ASX:AFI) has stepped up capital returns, combining an active on-market share buy-back with recently declared special dividends. This has put cash distributions and per share outcomes front and centre for investors. See our latest analysis for Australian Foundation Investment. While the latest special dividends and buy-back activity are front of mind, Australian Foundation Investment’s A$6.89...
ASX:HZN
ASX:HZNOil and Gas

Does Horizon Oil (ASX:HZN) Prioritising Dividends Amid Softer Earnings Reveal Its True Capital Allocation Stance?

Horizon Oil Limited recently announced a dividend of A$0.015 per share for the six months ended December 31, 2025, alongside half-year results showing sales of US$44.64 million and net income of US$2.36 million, both lower than the same period a year earlier. The decision to maintain a dividend despite weaker earnings highlights management’s focus on ongoing cash returns to shareholders, even as profitability softens. We’ll now examine how Horizon Oil’s decision to pay this dividend despite...
ASX:IGO
ASX:IGOMetals and Mining

IGO (ASX:IGO) Faces Tighter Kwinana Controls – What Do Health Risks Mean For Operational Flexibility?

The Department of Water and Environmental Regulation recently classified the Tianqi-IGO Kwinana lithium refinery as posing a “high” health risk, prompting tighter operating controls at the plant. This regulatory intervention highlights potential pressure points around compliance and operating flexibility at a refinery that is important to IGO’s lithium processing footprint. We will now examine how the tightened health controls at Kwinana shape IGO’s broader investment narrative and...
ASX:CBA
ASX:CBABanks

Alleged A$1 Billion AI-Linked Mortgage Fraud Could Be A Game Changer For Commonwealth Bank (ASX:CBA)

Commonwealth Bank of Australia has disclosed past exposure to a very limited portion of its own shares and reported itself to authorities over approximately A$1.00 billion in suspected illegitimate home loans allegedly enabled by forged documents and artificial intelligence, with police and regulators now investigating. By flagging that its controlled entities have no net economic exposure to its own voting shares while confronting a large-scale home loan fraud issue, the bank is...
ASX:NEC
ASX:NECMedia

Assessing Nine Entertainment Holdings’ Valuation After Profitability Jumps On Recent Half Year Earnings

Why Nine Entertainment Holdings (ASX:NEC) is Back on Investors’ Radar Nine Entertainment Holdings (ASX:NEC) has moved into the spotlight after its half year earnings update, where net income and earnings per share were far higher than the previous period despite softer sales. On the same day, the company also announced an ordinary dividend of A$0.045 per share for the six months to 31 December 2025, with an ex date of 9 March 2026 and payment scheduled for 23 April 2026. Together, these...
ASX:ZIP
ASX:ZIPConsumer Finance

What Zip Co (ASX:ZIP)'s A$50m Share Buyback Plan Means For Shareholders

Zip Co Limited has launched an on‑market share buyback plan, authorizing the repurchase of up to 92,161,082 shares (7.25% of its 1,270,683,586 issued shares) for A$50,000,000 through to March 5, 2027, following a Board approval on February 20, 2026, and it also presented at the Morgan Stanley Technology, Media & Telecom Conference 2026 at The Palace Hotel in San Francisco on March 2, 2026. This buyback reduces the pool of outstanding shares over time, which can increase each remaining...
ASX:BOE
ASX:BOEOil and Gas

Assessing Boss Energy’s Valuation After Broker Upgrade And Uranium Price Strength

Why Boss Energy is back on investor radars Boss Energy (ASX:BOE) has drawn fresh attention after a broker upgrade to a buy rating, with the case supported by its latest half year earnings, Honeymoon Project progress, and uranium price strength. See our latest analysis for Boss Energy. At A$1.74, Boss Energy’s recent share price return has been mixed, with a 4.19% 90 day gain and 11.18% year to date share price return sitting against a 27.20% 1 year total shareholder return decline. This...
ASX:NAB
ASX:NABBanks

National Australia Bank Leadership Changes Put Risk And Valuation In Focus

National Australia Bank (ASX:NAB) has announced the retirement of Group Chief Risk Officer Shaun Dooley, a 33-year veteran of the bank. Dooley has also been serving as acting Group Chief Financial Officer during a period of leadership change. NAB has appointed Inder Singh as the new Group Chief Financial Officer and Group Executive Strategy. These changes affect core leadership roles that oversee risk management, financial reporting and long term planning. As one of Australia’s major banks,...